EFTA01519444
EFTA01519445 DataSet-10
EFTA01519446

EFTA01519445.pdf

DataSet-10 1 page 120 words document
V15
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (120 words)
CHISLA INE MAXWELL - OAP IHD ACCT For the Period 2/1/14 to 2/28/14 Equity Summary Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation EAFE Equity 1.847.938.92 137,528.10 (1.710 410 82) 100% Current Market Value/Cost Period Value Market Value 137,528.10 Tax Cost 132,686.12 Unrealized Gain/Loss 4,841.98 Estimated Annual Income 5.106.04 Accrued Dividends 12,568.34 Yield 3.71% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield EAFE Equity ASTRAZENECA PLC 67.76 0.00 4.13% SPONS ADR 624.15 046353-10-8 AZN GLAXOSMITHKLINE PLC 55.94 0.00 4 41", SPONS ADR 684.77 37733W.10-5 GSK J.P.Morgan Account Page 4 of 15 Consolidated Statement Page 38 Confidential Treatment Requested by JPMorgan JPN1-SDNY-00046731 Chase CONFIDENTIAL SDNY_GM_00315929 EFTA01519445
ℹ️ Document Details
SHA-256
8246aa2b6d256474e78cfdba27075f6d910046049c8516a2998130619526ae7e
Bates Number
EFTA01519445
Dataset
DataSet-10
Document Type
document
Pages
1

Comments 0

Loading comments…
Link copied!